Santé

La santé permet la productivité économique et la prospérité, et est importante pour le bien-être de la société. Pour parvenir à une approche plus personnalisée et davantage centrée sur le patient et à un système de santé plus abordable financièrement, une politique efficace doit reposer sur des constats fondés et argumentés.

Technopolis Group conseille les décideurs publics et les responsables de programme pour mettre en place des plans d’action basés sur des objectifs précis. Nos consultants aident à mesurer le coût, les effets et les impacts d’une stratégie et d’investissements dans les sciences, les technologies et l’innovation de la santé. Grâce à notre connaissance approfondie des sciences de la vie et de la santé et notre grande expérience dans le planning stratégique et l’évaluation, nous participons à la mise en place de politiques publiques efficaces, pour une meilleure santé.

The impact of collaboration: the value of UK medical research to EU science and health

The UK has a strong medical research community; the country’s withdrawal from the European Union (EU) can therefore be expected to have implications not only for the UK, but also for EU science and health. To better understand the UK’s contribution to medical research and patient health in the EU, a new study was commissioned…

Voir le rapport

Review of the Product Development Partnerships Fund 2011-2014

Every year, poverty related diseases affect millions of people in the developing world. Yet, in the absence of clear profit potential, pharmaceutical companies are reluctant to invest in the development of treatments to fight these diseases. In response to this market failure, in the mid-1990s Product Development Partnerships (PDPs) emerged. PDPs use private sector approaches…

Voir le rapport

Evidence on mechanisms and tools for use of health information for decision-making

The World Health Assembly in 2005 urged Member States to establish or strengthen knowledge transfer mechanisms to support evidence-informed health policies and health care delivery. The European Health Information Initiative was set up to strengthen the use of evidence, information and research for policy-making in the WHO European Region. While good-quality health information is a key component for…

Voir le rapport

Assessing the research potential of access to clinical trial data

Clinical trials generate systematic and vital information about the efficacy, safety and quality of medical interventions. However, there has been much discussion about the degree to which trial results and the underpinning data are currently made available to researchers outside of the team that conducted the original trial. The primary aims of this study, commissioned…

Voir le rapport
En voir plus